vs
奎斯特诊断（IMDX）与阿帕奇（LASE）财务数据对比。点击上方公司名可切换其他公司
奎斯特诊断的季度营收约是阿帕奇的1.2倍（$1.1M vs $919.3K），阿帕奇净利率更高（-506.4% vs -2015.4%，领先1508.9%），阿帕奇同比增速更快（28.3% vs -23.4%），过去两年奎斯特诊断的营收复合增速更高（154.4% vs -3.9%）
奎斯特诊断公司是一家美国临床检验企业，跻身财富500强，业务覆盖美国本土，以及波多黎各、墨西哥、巴西等地区，同时与全球多家医院和诊所保持合作关系，是行业内颇具影响力的医疗诊断服务提供商。
IPG光子公司是光纤激光器制造商，研发并商业化推广光纤激光器产品，其产品广泛应用于材料加工、医疗、电信等多个领域，目前在美国、德国、俄罗斯和意大利均设有生产基地。
IMDX vs LASE — 直观对比
营收规模更大
IMDX
是对方的1.2倍
$919.3K
营收增速更快
LASE
高出51.6%
-23.4%
净利率更高
LASE
高出1508.9%
-2015.4%
两年增速更快
IMDX
近两年复合增速
-3.9%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.1M | $919.3K |
| 净利润 | $-23.0M | $-4.7M |
| 毛利率 | 42.5% | -20.1% |
| 营业利润率 | -2057.5% | -350.0% |
| 净利率 | -2015.4% | -506.4% |
| 营收同比 | -23.4% | 28.3% |
| 净利润同比 | 31.5% | -186.5% |
| 每股收益（稀释后） | $-0.75 | $-0.27 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IMDXLASE
| Q4 25 | $1.1M | — | ||
| Q3 25 | $260.0K | $919.3K | ||
| Q2 25 | $518.0K | $2.6M | ||
| Q1 25 | $2.1M | $2.3M | ||
| Q4 24 | $1.5M | $1.3M | ||
| Q3 24 | $115.0K | $716.7K | ||
| Q2 24 | $104.0K | $623.4K | ||
| Q1 24 | $176.0K | $743.0K |
净利润IMDXLASE
| Q4 25 | $-23.0M | — | ||
| Q3 25 | $-10.9M | $-4.7M | ||
| Q2 25 | $-9.7M | $-1.8M | ||
| Q1 25 | $-6.7M | $-1.7M | ||
| Q4 24 | $-33.5M | $586.4K | ||
| Q3 24 | $-13.5M | $-1.6M | ||
| Q2 24 | $-4.5M | $-934.3K | ||
| Q1 24 | $-9.1M | $-545.7K |
毛利率IMDXLASE
| Q4 25 | 42.5% | — | ||
| Q3 25 | 53.5% | -20.1% | ||
| Q2 25 | 67.6% | 53.5% | ||
| Q1 25 | 62.0% | 49.8% | ||
| Q4 24 | 40.0% | 13.3% | ||
| Q3 24 | 43.5% | 85.0% | ||
| Q2 24 | 48.1% | 50.6% | ||
| Q1 24 | 25.6% | 51.9% |
营业利润率IMDXLASE
| Q4 25 | -2057.5% | — | ||
| Q3 25 | -4249.2% | -350.0% | ||
| Q2 25 | -1900.0% | -37.0% | ||
| Q1 25 | -318.0% | -68.7% | ||
| Q4 24 | -2262.9% | -255.1% | ||
| Q3 24 | -11752.2% | -238.0% | ||
| Q2 24 | -4453.8% | -149.4% | ||
| Q1 24 | -5265.3% | -73.8% |
净利率IMDXLASE
| Q4 25 | -2015.4% | — | ||
| Q3 25 | -4174.6% | -506.4% | ||
| Q2 25 | -1880.7% | -68.3% | ||
| Q1 25 | -312.0% | -73.4% | ||
| Q4 24 | -2255.1% | 45.7% | ||
| Q3 24 | -11733.0% | -226.8% | ||
| Q2 24 | -4355.8% | -149.9% | ||
| Q1 24 | -5186.9% | -73.4% |
每股收益（稀释后）IMDXLASE
| Q4 25 | $-0.75 | — | ||
| Q3 25 | $-0.34 | $-0.27 | ||
| Q2 25 | $-0.30 | $-0.12 | ||
| Q1 25 | $-0.26 | $-0.12 | ||
| Q4 24 | $-2.19 | $0.06 | ||
| Q3 24 | $-0.98 | $-0.13 | ||
| Q2 24 | $-0.36 | $-0.09 | ||
| Q1 24 | $-1.13 | $-0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $11.6M | $3.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-31.5M | $4.1M |
| 总资产 | $25.8M | $17.5M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资IMDXLASE
| Q4 25 | $11.6M | — | ||
| Q3 25 | $18.7M | $3.6M | ||
| Q2 25 | $24.3M | $78.5K | ||
| Q1 25 | $31.0M | $179.1K | ||
| Q4 24 | $8.6M | $533.9K | ||
| Q3 24 | $3.4M | $2.1M | ||
| Q2 24 | $9.3M | $2.7M | ||
| Q1 24 | $5.6M | $5.2M |
股东权益IMDXLASE
| Q4 25 | $-31.5M | — | ||
| Q3 25 | $-9.2M | $4.1M | ||
| Q2 25 | $1.1M | $4.3M | ||
| Q1 25 | $10.2M | $6.8M | ||
| Q4 24 | $-12.3M | $10.2M | ||
| Q3 24 | $9.7M | $9.7M | ||
| Q2 24 | $22.7M | $10.3M | ||
| Q1 24 | $11.6M | $12.4M |
总资产IMDXLASE
| Q4 25 | $25.8M | — | ||
| Q3 25 | $43.9M | $17.5M | ||
| Q2 25 | $50.5M | $14.9M | ||
| Q1 25 | $60.4M | $16.0M | ||
| Q4 24 | $35.1M | $17.2M | ||
| Q3 24 | $70.2M | $10.6M | ||
| Q2 24 | $74.7M | $11.1M | ||
| Q1 24 | $71.0M | $13.6M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-5.5M | $763.1K |
| 自由现金流经营现金流 - 资本支出 | $-7.0M | — |
| 自由现金流率自由现金流/营收 | -616.7% | — |
| 资本支出强度资本支出/营收 | 129.9% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-25.4M | — |
8季度趋势，按日历期对齐
经营现金流IMDXLASE
| Q4 25 | $-5.5M | — | ||
| Q3 25 | $-4.5M | $763.1K | ||
| Q2 25 | $-6.3M | $-1.0M | ||
| Q1 25 | $-5.9M | $-1.2M | ||
| Q4 24 | $-5.4M | $-6.5M | ||
| Q3 24 | $-5.5M | $632.7K | ||
| Q2 24 | $-6.0M | $-2.4M | ||
| Q1 24 | $-3.8M | $-866.3K |
自由现金流IMDXLASE
| Q4 25 | $-7.0M | — | ||
| Q3 25 | $-5.6M | — | ||
| Q2 25 | $-6.6M | — | ||
| Q1 25 | $-6.2M | — | ||
| Q4 24 | $-5.6M | — | ||
| Q3 24 | $-5.6M | $589.6K | ||
| Q2 24 | $-6.2M | $-2.4M | ||
| Q1 24 | $-3.9M | $-1.0M |
自由现金流率IMDXLASE
| Q4 25 | -616.7% | — | ||
| Q3 25 | -2135.4% | — | ||
| Q2 25 | -1279.5% | — | ||
| Q1 25 | -288.4% | — | ||
| Q4 24 | -374.5% | — | ||
| Q3 24 | -4884.3% | 82.3% | ||
| Q2 24 | -5931.7% | -388.0% | ||
| Q1 24 | -2189.8% | -136.9% |
资本支出强度IMDXLASE
| Q4 25 | 129.9% | — | ||
| Q3 25 | 403.8% | — | ||
| Q2 25 | 67.4% | — | ||
| Q1 25 | 14.4% | — | ||
| Q4 24 | 14.4% | — | ||
| Q3 24 | 75.7% | 6.0% | ||
| Q2 24 | 183.7% | 5.1% | ||
| Q1 24 | 13.6% | 20.3% |
现金转化率IMDXLASE
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -11.11× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
